Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]
Heather J. Cordell(Newcastle University), Ann Spicer(University of Cambridge), Jinyoung Byun(Dartmouth College), Catherine Vincent(University of Padua), Younghun Han(University of New Mexico), Rosanna Asselta(Humanitas University), Julie Horowitz(Regeneron (United States)), Yosuke Kawai(Tohoku University), Yuki Hitomi(National Center for Global Health and Medicine), Konstantinos N. Lazaridis(Mayo Clinic), Masao Nagasaki(Kyushu University), James J. Fryett(Newcastle University), Marco Carbone(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Gideon M. Hirschfield(University Health Network), Christopher I. Amos(The University of Texas MD Anderson Cancer Center), Rebecca Darlay(Newcastle University), Aris Baras(Regeneron (United States)), George Mells(Cambridge University Hospitals NHS Foundation Trust), Elizabeth J. Atkinson(Mayo Clinic in Arizona), Mariza de Andrade(Mayo Clinic), Katsushi Tokunaga(National Center for Global Health and Medicine), Alessio Gerussi, Angela Cheung(Mayo Clinic), Seik‐Soon Khor(The University of Tokyo), Kazuko Ueno(The University of Tokyo), Katherine A. Siminovitch(Mount Sinai Hospital), Xiong Ma(Shanghai Jiao Tong University), Olivier Gervais(Kyoto University), Pietro Invernizzi(Azienda Ospedaliera San Gerardo), Yoshihiro Aiba(Nagasaki Medical Center), Steven Flack(University of Cambridge), Andrew L. Mason(Ochsner Medical Center), Manuel A. R. Ferreira(Broad Institute), Victoria Mulcahy(University of Cambridge), Gang Xie(Mount Sinai Hospital), Zhiqiang Li(Qingdao University), Jinyi Zhang(China Three Gorges University), Minae Kawashima(The University of Tokyo), Richard Sandford(University of Cambridge), Nao Nishida(National Center for Global Health and Medicine), Dylan Sun(Regeneron (United States)), Ruqi Tang(Shanghai Jiao Tong University), Minoru Nakamura(Hokkaido University of Science), David E.J. Jones(NIHR Newcastle Biomedical Research Centre), Brian D. Juran(Mayo Clinic), Yongyong Shi(Shanghai University of Sport), Michael F. Seldin(University of California, Davis)
Cited by 1
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k